Quantinno Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.2M Buy
661,397
+117,534
+22% +$16.5M 0.15% 102
2025
Q4
$66.8M Buy
543,863
+151,329
+39% +$18.4M 0.13% 124
2025
Q3
$43.6M Buy
392,534
+122,515
+45% +$13.9M 0.12% 166
2025
Q2
$29.9M Buy
270,019
+87,191
+48% +$9.28M 0.13% 147
2025
Q1
$20.5M Buy
182,828
+42,903
+31% +$4.43M 0.13% 148
2024
Q4
$12.9M Buy
139,925
+58,305
+71% +$5.25M 0.13% 137
2024
Q3
$6.84M Buy
81,620
+48,910
+150% +$3.73M 0.09% 244
2024
Q2
$2.24M Sell
32,710
-34,121
-51% -$2.28M 0.04% 532
2024
Q1
$4.89M Buy
66,831
+28,999
+77% +$2.23M 0.11% 200
2023
Q4
$3.06M Buy
37,832
+5,197
+16% +$404K 0.11% 234
2023
Q3
$2.45M Sell
32,635
-10,714
-25% -$824K 0.11% 224
2023
Q2
$3.34M Buy
43,349
+10,949
+34% +$873K 0.19% 89
2023
Q1
$2.69M Buy
32,400
+5,039
+18% +$417K 0.18% 115
2022
Q4
$2.35M Buy
27,361
+10,330
+61% +$818K 0.18% 142
2022
Q3
$1.05M Buy
17,031
+9,155
+116% +$577K 0.14% 202
2022
Q2
$487K Buy
+7,876
New +$488K 0.07% 342

Other funds holding GILD

Quantinno Capital Management's GILD Position: Q1 2026 in Review

Quantinno Capital Management increased its Gilead Sciences (GILD) stake by 22% in Q1 2026, buying an estimated $16.5M and bringing the position to 661,397 shares worth $92.2M. The position accounts for 0.15% of the portfolio, ranked #102.

Quantinno Capital Management first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Quantinno Capital Management held 661,397 shares of Gilead Sciences worth $92.2M as of Q1 2026.
  • Quantinno Capital Management bought 117,534 Gilead Sciences shares in Q1 2026, an estimated $16.5M.
  • Gilead Sciences made up 0.15% of Quantinno Capital Management's portfolio in Q1 2026, its #102 holding.
  • Quantinno Capital Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.